Catharina Ziekenhuis Stichting

At Catharina Ziekenhuis Stichting in Eindhoven, a major focus is cardiovascular disease research, with studies addressing atherosclerotic cardiovascular disease, acute coronary syndrome, atrial fibrillation, and myocardial infarction. The trials are mainly designed to test new ways to prevent heart attacks and stroke, reduce clot-related complications, and improve long-term cardiovascular outcomes.

• Preventing major adverse cardiovascular events in people at high risk
• Reducing stroke and systemic embolism in atrial fibrillation
• Evaluating safer and more effective antithrombotic treatment strategies

This work reflects a strong interest in both heart and vascular medicine, with emphasis on better protection against recurrent events and treatment-related bleeding risk.

The site also has an active program in oncology and hematologic cancers, including prostate cancer, colorectal cancer, gastric cancer, esophageal cancer, cervical cancer, endometrial cancer, pleural mesothelioma, diffuse large B-cell lymphoma, and leukemia. These trials are aimed at improving survival, strengthening disease control, and refining treatment approaches for both solid tumors and blood cancers.

• Testing new combinations for advanced and high-risk cancers
• Improving outcomes after surgery or chemoradiation
• Exploring more effective options for relapsed or difficult-to-treat blood cancers

The research portfolio includes both treatment intensification and treatment optimization, showing a broad effort to improve cancer care across several disease types.

In Obstetrics & Gynaecology, the research includes female urogenital diseases, pregnancy complications, subfertility, and recurrent miscarriage. Studies at the Catharina Ziekenhuis Stichting are focused on preserving fertility, supporting early pregnancy, and improving outcomes for women with gynecologic cancers and reproductive health concerns.

• Assessing fertility-sparing approaches in cervical cancer
• Improving live birth rates in subfertility treatment
• Evaluating therapies for unexplained recurrent miscarriages

This area combines cancer care with reproductive medicine, highlighting a patient-centered effort to protect both health and future fertility.

The trial portfolio also covers digestive system diseases, respiratory tract diseases, and immune-related conditions. Research topics include acute pancreatitis, esophageal surgery-related infections, and pulmonary sarcoidosis, with studies designed to reduce complications, improve recovery, and better control inflammatory disease activity.

• Lowering organ failure and mortality in acute pancreatitis
• Preventing infectious complications after esophagectomy
• Assessing new treatment options for pulmonary sarcoidosis

This research shows a practical focus on improving supportive care and treatment effectiveness in complex medical conditions that affect the digestive and respiratory systems.

The site’s studies in reproductive and urinary physiological phenomena include investigations into treatment strategies that may preserve organ function and support quality of life, especially in patients with prostate cancer and gynecologic malignancies. These trials aim to refine treatment timing and intensity while balancing disease control with functional outcomes.

• Exploring treatment strategies that may reduce long-term toxicity
• Supporting function preservation alongside cancer control
• Evaluating approaches that may improve patient quality of life

This field adds an important functional dimension to the broader oncology program, linking cancer treatment with everyday well-being.